Management of Hypergranulation Tissue with Active Infection

Initial Management

• The American College of Hypergranulation Tissue Management recommends cleaning the affected wound at least once daily using an antimicrobial cleanser to reduce bacterial load and control infection 1
• Apply a topical antimicrobial agent under any fixation device to address the active infection, as suggested by Clinical Nutrition 2, 1
• Use foam dressings rather than gauze to reduce skin maceration, as foam lifts drainage away from the skin, according to Clinical Nutrition 2, 3
• Apply a barrier film or cream to protect surrounding skin, especially if the hypergranulation tissue is exuding, as recommended by Praxis Medical Insights 1
• For fungal infections, apply topical antifungal agents, as suggested by Clinical Nutrition 2, 3

Treatment Options for Hypergranulation Tissue

• Apply a foam or silver dressing over the affected area, changing only when significant exudate is present (at least weekly), as recommended by Clinical Nutrition and Praxis Medical Insights 4, 1
• Consider topical corticosteroid cream or ointment for 7-10 days in combination with a foam dressing to provide compression to the treatment site, according to Clinical Nutrition and Praxis Medical Insights 4, 1
• For persistent hypergranulation, consider cauterization with silver nitrate applied directly onto the overgranulation tissue, as suggested by Clinical Nutrition and Praxis Medical Insights 2, 4, 1

Advanced Interventions

• For refractory cases, consider surgical removal of the hypergranulation tissue, as recommended by Clinical Nutrition and Praxis Medical Insights 4, 1
• Argon plasma coagulation has been described as an effective treatment in literature for persistent cases, according to Clinical Nutrition 4, 3
• Negative Pressure Wound Therapy (NPWT) may be beneficial for extensive wounds with hypergranulation tissue to promote healthy granulation and wound healing, as suggested by World Journal of Emergency Surgery and International Journal of Surgery 5, 6

Special Considerations for Tube-Related Hypergranulation

• Verify proper tension between internal and external bolsters if hypergranulation is around a tube site, as recommended by Clinical Nutrition 2, 3
• Avoid unnecessary tube movement or excessive pressure, as suggested by Clinical Nutrition 2, 3
• Consider stabilizing the tube using a clamping device or switching to a low-profile device if side torsion is contributing to hypergranulation, according to Clinical Nutrition 2, 3

Common Pitfalls to Avoid

• Avoid using gauze dressings directly on hypergranulation tissue as they can adhere to the tissue and cause trauma upon removal, as recommended by Praxis Medical Insights 1
• Do not replace tubes with larger-diameter tubes as this is generally ineffective and can result in an enlarged stoma tract with more leakage, according to Clinical Nutrition 3

Monitoring and Follow-up

• Regularly assess the wound for signs of improvement or deterioration, as recommended by Praxis Medical Insights 1
• If hypergranulation persists despite treatment, consider alternative approaches or combinations of treatments, as suggested by Clinical Nutrition and Praxis Medical Insights 4, 1

Management of Hypergranulation Tissue with Clobetasol

Topical Corticosteroid Application

• The British Association of Dermatologists recommends clobetasol propionate 0.05% cream or ointment applied topically to affected areas in pediatric patients 7

Treatment Duration and Dressing

• Clobetasol propionate 0.05% cream or ointment should be applied directly to the hypergranulation tissue twice daily, covered with a foam dressing to provide compression, for a limited treatment duration of 7-10 days 7

Management of Hypergranulation in Wound Healing

Diagnosis and Identification

• The presence of granulation tissue separating skin edges is a sign of hypergranulation, which requires intervention, according to the International Journal of Surgery 8

Treatment Options

• The application of topical corticosteroid (triamcinolone 0.05% or clobetasol 0.05%) combined with foam dressing for 7-10 days can achieve hypergranulation resolution in 95.7% of patients, as reported in a 2024 burn center study 8
• Silver nitrate cauterization can be used as a second-line treatment for persistent cases of hypergranulation, with only 4.3% of patients requiring this escalation in the 2024 study 8

Special Considerations

• In the context of open abdomen wounds, granulation tissue formation is encouraged in Grade 4 wounds where fascial closure is no longer possible, as it creates a suitable surface for skin grafting, as noted in the International Journal of Surgery 8, 9, 10, 11

Critical Pitfalls to Avoid

• The use of gauze dressings directly on hypergranulation tissue should be avoided, as they adhere to the tissue and cause trauma upon removal, according to the International Journal of Surgery 8

Management of Hypergranulation Tissue Around New PEG Tubes

First‑Line Treatment

Mechanical and Device‑Related Considerations

Second‑Line Treatment for Refractory Cases

Third‑Line Treatment for Persistent Cases

Critical Pitfalls to Avoid

Guideline for Trichloroacetic Acid Cauterization of Hypergranulation Tissue

Indications and Treatment Protocol

• Second‑line therapy: Apply 80–90 % trichloroacetic acid (TCA) directly to hypergranulation tissue when first‑line topical corticosteroids have failed, repeating weekly for up to six applications before considering surgical excision or argon plasma coagulation. 13

Concentration and Application Technique

• Recommended concentration: Use TCA at 80–90 % strength, the standard range endorsed in clinical guidelines for tissue cauterization. 13
• Targeted application: Apply the acid only to the granulation tissue itself, avoiding any contact with surrounding healthy skin or mucosa. 13 & 14
• Neutralization step: Immediately after acid application, powder the treated area with talc or sodium bicarbonate to neutralize any unreacted TCA and prevent spread to adjacent tissue. 13 & 14
• Visualization: Perform the procedure under direct visualization with adequate lighting and, when feasible, magnification to ensure precise delivery. 14

Safety Precautions

• Exclusive targeting: Restrict the chemical cauterization to the intended tissue to avoid collateral damage; the acid causes instantaneous tissue destruction on contact. 13 & 14
• Avoid bilateral cautery: Do not cauterize opposing surfaces (e.g., both sides of a nasal septum) simultaneously, as this markedly increases the risk of perforation. 14
• Area limitation: Never treat an area larger than necessary; excess application will destroy any tissue it contacts. 13

Limits and Alternative Therapies

• Maximum treatment course: Do not exceed six weekly applications (approximately six weeks) without reassessing the patient; persistent granulation tissue after this point warrants alternative interventions such as surgical excision or argon plasma coagulation. 13

Management of Hypergranulation Tissue at PEG Tube Sites

First‑Line Management

Daily Wound Care

• Clean the peristomal skin at least once daily with an antimicrobial cleanser to lower bacterial load and control subclinical colonization. 15
• Apply a zinc‑oxide–based barrier film or cream to protect surrounding skin, especially when the granulation tissue is exuding. 15
• Use foam dressings rather than gauze; foam lifts drainage away from the skin while gauze can cause maceration and trauma to friable tissue. 15

Topical Corticosteroid Therapy

• Apply clobetasol propionate 0.05 % (or triamcinolone 0.05 %) directly to the hypergranulation tissue twice daily for 7–10 days, covered with a foam dressing that provides gentle compression. 15
• This regimen resolves hypergranulation in the vast majority of patients, with only about 4.3 % requiring escalation to second‑line therapy. 15

Mechanical Contributing Factors

• Verify that the external bolster allows at least 5 mm of free tube movement to avoid excessive tension. 16
• Ensure the tube does not exert excessive pressure or side‑torsion, which can enlarge the stoma tract and promote granulation tissue formation. 15
• Correct common mechanical issues:
  
  • Excess moisture from leakage around the tube. 15
  • Excessive friction or movement from a poorly secured tube. 15
  • Critical colonization or infection that warrants antimicrobial therapy. 15

Second‑Line Treatment (Failure of Topical Corticosteroids)

• Apply silver nitrate directly to the overgranulation tissue when corticosteroids have failed after 7–10 days. This provides an effective bridge before more invasive options. [15][17]

Third‑Line Treatment (Refractory Cases)

• Perform surgical excision of the hypergranulation tissue when both corticosteroids and silver nitrate are ineffective. 15
• Use argon plasma coagulation as an alternative third‑line modality for persistent lesions. 15
• Consider switching to an alternative brand or type of gastrostomy tube if mechanical failure persists despite all other interventions. 15

Guideline Recommendations

• The 2022 ESPEN practical guideline on home enteral nutrition outlines this stepwise escalation from topical therapy through cauterization to surgical removal. 15
• The 2025 AGA update reinforces the same principles without contradiction. 18

Critical Pitfalls to Avoid

• Do not use gauze dressings directly on hypergranulation tissue; they adhere to vascular tissue and cause bleeding and trauma upon removal. 15
• Avoid replacing the PEG tube with a larger‑diameter tube, as this enlarges the stoma tract and increases leakage. 15
• Do not apply hydrogen peroxide after the first week post‑placement; it irritates the skin and contributes to stomal complications. 17
• Do not rely on topical antibiotics alone for hypergranulation management; they are not indicated. 15
• Never make the external bolster too tight; excessive pressure between bolsters promotes tissue overgrowth. [15][16]

Infection Considerations

• If active infection co‑exists with hypergranulation, apply a topical antimicrobial agent beneath the fixation device. 15
• Use foam or silver‑impregnated dressings that provide sustained antimicrobial activity. 15
• Reserve systemic antibiotics for cases where local therapy fails to resolve the site infection. 15

Algorithm Summary (Evidence‑Based Steps)